Quaker Wealth Management
IONS icon

Quaker Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History

Quaker Wealth Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$626 Sell
14
-1
-7% -$57 ﹤0.01% 667
2026
Q2 		$1.19K Hold
15
– – ﹤0.01% 543
2026
Q1 		$1.13K Buy
15
+1
+7% +$79 ﹤0.01% 508
2025
Q4 		$1.11K Hold
14
– – ﹤0.01% 520
2025
Q3 		$916 Hold
14
– – ﹤0.01% 483
2025
Q2 		$554 Buy
+14
New +$458 ﹤0.01% 589

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Tweedy, Browne Co
Tweedy, Browne Co Stamford, Connecticut $1.23B AUM 16.54% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Quaker Wealth Management's IONS Position: Q3 2026 in Review

Quaker Wealth Management reduced its Ionis Pharmaceuticals (IONS) stake by 6.7% in Q3 2026, selling an estimated $57 and leaving 14 shares worth $626. The position accounts for ﹤0.01% of the portfolio, ranked #667.

Quaker Wealth Management first reported a position in IONS in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.19K in Q2 2026. 210 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Quaker Wealth Management held 14 shares of Ionis Pharmaceuticals worth $626 as of Q3 2026.
  • Quaker Wealth Management sold 1 Ionis Pharmaceuticals share in Q3 2026, an estimated $57.
  • Ionis Pharmaceuticals made up ﹤0.01% of Quaker Wealth Management's portfolio in Q3 2026, its #667 holding.
  • Quaker Wealth Management first reported a position in Ionis Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • Quaker Wealth Management's Ionis Pharmaceuticals position peaked at $1.19K in Q2 2026.
  • 210 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.